796 reports of this reaction
5.3% of all AMPHETAMINE reports
#3 most reported adverse reaction
COMPLETED SUICIDE is the #3 most commonly reported adverse reaction for AMPHETAMINE, manufactured by Amneal Pharmaceuticals NY LLC. There are 796 FDA adverse event reports linking AMPHETAMINE to COMPLETED SUICIDE. This represents approximately 5.3% of all 14,926 adverse event reports for this drug.
Patients taking AMPHETAMINE who experience completed suicide should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
COMPLETED SUICIDE is moderately reported among AMPHETAMINE users, representing a notable but not dominant share of adverse events.
In addition to completed suicide, the following adverse reactions have been reported for AMPHETAMINE:
The following drugs have also been linked to completed suicide in FDA adverse event reports:
COMPLETED SUICIDE has been reported as an adverse event in 796 FDA reports for AMPHETAMINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
COMPLETED SUICIDE accounts for approximately 5.3% of all adverse event reports for AMPHETAMINE, making it one of the most commonly reported side effect.
If you experience completed suicide while taking AMPHETAMINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.